The 3 Most Profit-Friendly Biotech Stocks
Developing game-changing medicine isn't easy, and it's certainly not cheap. It can cost hundreds of millions of dollars to create new drugs, and with a clinical trial failure rate of 90%, the risks to biotech companies are enormous.
from Biotech News
0 Comments